These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24160896)

  • 1. Estimating error rates in bioactivity databases.
    Tiikkainen P; Bellis L; Light Y; Franke L
    J Chem Inf Model; 2013 Oct; 53(10):2499-505. PubMed ID: 24160896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Training based on ligand efficiency improves prediction of bioactivities of ligands and drug target proteins in a machine learning approach.
    Sugaya N
    J Chem Inf Model; 2013 Oct; 53(10):2525-37. PubMed ID: 24020509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.
    Daina A; Michielin O; Zoete V
    Nucleic Acids Res; 2019 Jul; 47(W1):W357-W364. PubMed ID: 31106366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MQN-mapplet: visualization of chemical space with interactive maps of DrugBank, ChEMBL, PubChem, GDB-11, and GDB-13.
    Awale M; van Deursen R; Reymond JL
    J Chem Inf Model; 2013 Feb; 53(2):509-18. PubMed ID: 23297797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of commercial and public bioactivity databases.
    Tiikkainen P; Franke L
    J Chem Inf Model; 2012 Feb; 52(2):319-26. PubMed ID: 22145975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward understanding the molecular basis for chemical allosteric modulator design.
    Wang Q; Zheng M; Huang Z; Liu X; Zhou H; Chen Y; Shi T; Zhang J
    J Mol Graph Model; 2012 Sep; 38():324-33. PubMed ID: 23085171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors.
    Sato T; Yuki H; Takaya D; Sasaki S; Tanaka A; Honma T
    J Chem Inf Model; 2012 Apr; 52(4):1015-26. PubMed ID: 22424085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Interfaces as Targets in Drug Discovery.
    Fattorusso C; Persico M
    Curr Top Med Chem; 2015; 15(20):2003-4. PubMed ID: 26156196
    [No Abstract]   [Full Text] [Related]  

  • 10. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
    Cases M; Mestres J
    Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
    Nowotka MM; Gaulton A; Mendez D; Bento AP; Hersey A; Leach A
    Expert Opin Drug Discov; 2017 Aug; 12(8):757-767. PubMed ID: 28602100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs.
    Giangreco I; Cosgrove DA; Packer MJ
    J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
    Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
    J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCEAN: Optimized Cross rEActivity estimatioN.
    Czodrowski P; Bolick WG
    J Chem Inf Model; 2016 Oct; 56(10):2013-2023. PubMed ID: 27668814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation in Small-Molecule-Druggable Chemical Space: Where are the Initial Modulators of New Targets Published?
    Ashenden SK; Kogej T; Engkvist O; Bender A
    J Chem Inf Model; 2017 Nov; 57(11):2741-2753. PubMed ID: 29068231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PubChem 2019 update: improved access to chemical data.
    Kim S; Chen J; Cheng T; Gindulyte A; He J; He S; Li Q; Shoemaker BA; Thiessen PA; Yu B; Zaslavsky L; Zhang J; Bolton EE
    Nucleic Acids Res; 2019 Jan; 47(D1):D1102-D1109. PubMed ID: 30371825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated extraction of information on chemical-P-glycoprotein interactions from the literature.
    Yoshida S; Yamashita F; Ose A; Maeda K; Sugiyama Y; Hashida M
    J Chem Inf Model; 2013 Oct; 53(10):2506-10. PubMed ID: 24010770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.